Long-term and quality of survival in patients treated for acute lymphoblastic leukemia during the pediatric age.
acute lymphoblastic leukemia
pediatric leukemia
survival
Journal
Hematology reports
ISSN: 2038-8322
Titre abrégé: Hematol Rep
Pays: Switzerland
ID NLM: 101556723
Informations de publication
Date de publication:
05 Mar 2021
05 Mar 2021
Historique:
received:
18
08
2020
accepted:
30
10
2020
entrez:
22
3
2021
pubmed:
23
3
2021
medline:
23
3
2021
Statut:
epublish
Résumé
Long-term survival for acute lymphoblastic leukemia (ALL) in children improved over the last three decades up to 80-90% of affected patients. Consequently, the quality of life of survivors has become increasingly important. This study analyses the clinical features and outcome of 119 children with ALL, focusing on the quality of long-term survival in a subset of 22 patients over 18 years of age. Among this group, the 10-year event-free survival and overall survival were 83.1% (C.I. 74.0-89.2) and 88.4% (C.I. 80.9-93.1), respectively. Treatment related long-term medical complications were reported only in 2 patients (9.1%). Secondary school was completed successfully in 20 of 22 patients (89.9%). The remaining 2 patients were still attending at the time of the analysis. In conclusion, current treatment for ALL is well tolerated and does not compromise significantly the quality of life of survivors.
Identifiants
pubmed: 33747412
doi: 10.4081/hr.2021.8847
pmc: PMC7967269
doi:
Types de publication
Journal Article
Langues
eng
Pagination
8847Informations de copyright
©Copyright: the Author(s).
Déclaration de conflit d'intérêts
Conflict of interest: the authors declare no conflict of interests.
Références
Pediatr Blood Cancer. 2004 Jun;42(7):589-97
pubmed: 15127413
J Clin Oncol. 2012 May 10;30(14):1663-9
pubmed: 22412151
Pediatrics. 1988 Jan;81(1):127-33
pubmed: 3422112
Expert Rev Hematol. 2011 Apr;4(2):185-97
pubmed: 21495928
J Clin Oncol. 2015 Feb 20;33(6):610-5
pubmed: 25605853
Haematologica. 2019 Sep;104(9):1812-1821
pubmed: 30705097
Leukemia. 2010 Feb;24(2):255-64
pubmed: 20016536
Blood. 2011 Feb 24;117(8):2340-7; quiz 2556
pubmed: 21148812
J Clin Oncol. 2016 Sep 20;34(27):3240-7
pubmed: 27382091
Pediatr Blood Cancer. 2008 Feb;50(2 Suppl):509-16; discussion 517
pubmed: 18064646
Blood. 2010 Apr 22;115(16):3206-14
pubmed: 20154213
Leukemia. 2010 Feb;24(2):320-34
pubmed: 20016537
Haematologica. 2016 Nov;101(11):1295-1305
pubmed: 27742768
Expert Opin Pharmacother. 2013 Aug;14(11):1497-513
pubmed: 23705955
Fertil Steril. 2011 Oct;96(4):837-42
pubmed: 21868007
Eur J Cancer. 2007 May;43(7):1134-40
pubmed: 17383867
Hematol Oncol. 2019 Dec;37(5):609-616
pubmed: 31523837
Turk J Haematol. 2018 Aug 1;36(1):1-11
pubmed: 30398158
Pediatr Hematol Oncol. 1997 Nov-Dec;14(6):513-24
pubmed: 9383804
J Clin Oncol. 2007 Apr 20;25(12):1498-504
pubmed: 17442991